Effect of leukocyte hydrolases on bacteria. XV. Inhibition by antibiotics, metabolic inhibitors, and ultraviolet irradiation of the release by leukocyte extracts, trypsin, and lysozyme of lipopolysaccharide from gram-negative bacteria.
Leukocyte extracts, trypsin, and lysozyme are all capable of releasing the bulk of the LPS from S. typhi, S. typhimurium, and E. coli. Bacteria which have been killed by heat, ultraviolet irradiation, or by a variety of metabolic inhibitors and antibiotics which affect protein, DNA, RNA, and cell wall synthesis no longer yield soluble LPS following treatment with the releasing agents. On the other hand, bacteria which are resistant to certain of the antibiotics yield nearly the full amount of soluble LPS following treatment, suggesting that certain heatlabile endogenous metabolic pathways collaborate with the releasing agents in the release of LPS from the bacteria. It is suggested that some of the beneficial effects of antibiotics on infections with gram-negative bacteria may be the prevention of massive release of endotoxin by leukocyte enzymes in inflammatory sites.
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D004926:Escherichia coli / Q000378:metabolism* / Q000528:radiation effects; D006801:Humans; D008070:Lipopolysaccharides / Q000378:metabolism*; D009113:Muramidase / Q000494:pharmacology*; D012485:Salmonella typhi / Q000378:metabolism* / Q000528:radiation effects; D012486:Salmonella typhimurium / Q000378:metabolism* / Q000528:radiation effects; D014357:Trypsin / Q000494:pharmacology*; D014405:Tuftsin / Q000494:pharmacology*; D014466:Ultraviolet Rays; D005719:gamma-Globulins / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D008070:Lipopolysaccharides; D005719:gamma-Globulins; D009113:Muramidase; D014357:Trypsin; D014405:Tuftsin